Advertisement
Screener

ZYMEWORKS INC. (ZYME) Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

ZYMEWORKS INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

ZYMEWORKS INC. (ZYME) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $3.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-02.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-03-02

  • ZYMEWORKS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $3.10M, a 16.57% increase from fiscal 2023.
  • ZYMEWORKS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $2.66M, a 17.82% decline from fiscal 2022.
  • ZYMEWORKS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $3.24M, a 36.46% decline from fiscal 2021.
  • ZYMEWORKS INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2021 was $5.10M, a 25.30% increase from fiscal 2020.
Period endEffective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month
2024-12-31$3.10M
10-K · filed 2026-03-02
2023-12-31$2.66M
10-K · filed 2026-03-02
2022-12-31$3.24M
10-K · filed 2025-03-05
2021-12-31$5.10M
10-K · filed 2024-03-06
2020-12-31$4.07M
10-K · filed 2023-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Septerna, Inc. (SEPN)United States$1.783B-63.01
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Xencor Inc (XNCR)United States$1.776B-7.33